山东大学学报 (医学版) ›› 2018, Vol. 56 ›› Issue (10): 79-85.doi: 10.6040/j.issn.1671-7554.0.2017.985
• • 上一篇
陈希彦1,2,王琪1,2,顾伟亭3,文勇1,2
CHEN Xiyan1,2, WANG Qi1,2, GU Weiting3, WEN Yong1,2
摘要: 目的 探讨干扰TAZ基因后对舌鳞癌细胞CAL27增殖和凋亡的影响以及可能的分子调控机制。 方法 实验分为干扰组和对照组,将稳定干扰TAZ基因的慢病毒载体转染至舌鳞癌细胞CAL27中作为干扰组,并以非特异性序列转染CAL27细胞作为对照组。利用实时荧光定量PCR(RT-PCR)及Western blotting检测干扰效率,CCK-8细胞活力实验及EdU染色法检测转染后细胞增殖能力的改变,流式细胞术检测细胞周期和细胞凋亡情况,Western blotting检测与周期及凋亡相关蛋白的表达情况。 结果 干扰TAZ基因后,RT-PCR和Western blotting检测结果显示,TAZ mRNA和蛋白表达水平明显降低;CCK-8细胞增殖活力检测及EdU染色法显示细胞增殖能力降低;细胞早期凋亡和晚期凋亡比例均增多; G0/G1期细胞比例增多,而G2/M期细胞减少。同时,干扰TAZ基因后,周期相关蛋白CYCLIN D1、CDK4和CDK6等表达水平降低;而凋亡相关蛋白Bax、cleaved Caspase9表达水平均升高,Bcl-2表达水平降低。 结论 干扰TAZ基因可以通过调控细胞周期和凋亡相关蛋白的表达,来影响舌鳞癌细胞的增殖和凋亡。
中图分类号:
[1] 杨凯, 温玉明, 李龙江, 等. 舌鳞状细胞癌预后因素的探讨[J]. 华西口腔医学杂志, 2001, 19(3): 161-163. YANG Kai, WEN Yuming, LI Longjiang, et al. Investigation of the tongue squamous cell carcinoma prognostic factors[J]. West China Joural of Stomatology, 2001, 19(3): 161-163. [2] 郑家伟, 李金忠, 钟来平, 等. 口腔鳞状细胞癌临床流行病学研究现状[J]. 中国口腔颌面外科杂志, 2007, 5(2): 83-90. ZHENG Jiawei, LI Jinzhong, ZHONG Laiping, et al. Clinical epidemiology and risk factors of oral squamous cell carcinoma: An overview[J]. China Journal of Oral and Maxillofacial Surgery, 2007, 5(2): 83-90. [3] Chaturvedi AK, Anderson WF, Lortet-Tieulent J, et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers[J]. J Clin Oncol, 2013, 31(36): 4550-4559. [4] Chi AC, Day TA, Neville BW. Oral cavity and oropharyngeal squamous cell carcinoma-an update[J]. CA Cancer J Clin, 2015, 65(5): 401-421. [5] Zhao B, Tumaneng K, Guan KL. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal[J]. Nat Cell Biol, 2011, 13(8): 877-883. [6] Harvey KF. Growth control: re-examining Zyxin's role in the hippo pathway[J]. Curr Biol, 2015, 25(6): R230-R231. [7] Harvey KF, Zhang X, Thomas DM. The Hippo pathway and human cancer[J]. Nat Rev Cancer, 2013, 13(4): 246-257. [8] Wang J, Rouse C, Jasper JS, et al. ABL kinases promote breast cancer osteolytic metastasis by modulating tumor-bone interactions through TAZ and STAT5 signaling[J]. Sci Signal, 2016, 9(413): 12. doi: 10.1126/scisignal.aad3210. [9] Xiao H, Jiang N, Zhou B, et al. TAZ regulates cell proliferation and epithelial-mesenchymal transition of human hepatocellular carcinoma[J]. Cancer Sci, 2015, 106(2): 151-159. [10] Buglioni S, Vici P, Sergi D, et al. Analysis of the hippo transducers TAZ and YAP in cervical cancer and its microenvironment[J]. Oncoimmunology, 2016, 5(6): e1160187. doi: 10.1080/2162402X.2016.1160187. [11] Li YW, Shen H, Frangou C, et al. Characterization of TAZ domains important for the induction of breast cancer stem cell properties and tumorigenesis[J]. Cell Cycle, 2015, 14(1): 146-156. [12] Hiemer SE, Zhang L, Kartha VK, et al. A YAP/TAZ-regulated molecular signatureis associated with oral squamous cell carcinoma[J]. Mol Cancer Res, 2015, 13(6): 957-968. [13] Jotte RM, Spigel DR. Advances in molecular-based personalized non-small-cell lung cancer therapy: targeting epidermal growth factor receptor and mechanisms of resistance[J]. Cancer Med, 2015, 4(11): 1621-1632. [14] Rosell R, Carcereny E, Gervais R, et al. Erlotinib versus standard chemotherapy as fi rst-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer(EURTAC): a multicentre, open-label, randomised phase 3 trial[J]. Lancet Oncol, 2012, 13(3): 239. [15] Edgar BA. From cell structure to transcription: Hippo forges a new path[J]. Cell, 2006, 124(2): 267-273. [16] Xie D, Cui J, Xia T, et al. Hippo transducer TAZ promotes epithelial mesenchymal transition and supports pancreatic cancer progression[J]. Oncotarget, 2015, 6(34): 35949-35963. [17] Di Benedetto A, Mottolese M, Sperati F, et al. Association between AXL, Hippo Transducers, and survival outcomes in male breast cancer[J]. J Cell Physiol, 2017, 232(8): 2246-2252. [18] Li Z, Wang Y, Zhu Y, et al. The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer[J]. Mol Oncol, 2015, 9(6): 1091-1105. [19] Gandhirajan RK, Jain M, Walla B, et al. Cysteine S-glutathionylation promotes ptability and activation of the Hippo downstream effector transcriptional co-activator with PDZ-binding motif(TAZ)[J]. J Biol Chem, 2016, 291(22): 11596-11607. [20] 袁丽, 郭硕, 曹颖, 等. Bcl-2基因多态性与食管癌及癌前病变发病风险的相关性[J]. 肿瘤, 2015, 35(12): 1322-1328. YUAN Li, GUO Shuo, CAO Ying, et al. Association between Bcl-2 gene polymorphism and risk of esophageal squamous cell carcinoma and precancerous lesions[J]. Tumor, 2015, 35(12):1322-1328. [21] 郑虹, 耿明. HSP70、Caspase3在胶质细胞瘤中的表达及与肿瘤病理分级的关系[J]. 山东大学学报(医学版), 2007, 45(9): 944-946. ZHENG Hong, GENG Ming. Expression of HSP70 and Caspase3 in human glioma and its relationship with pathological grades[J]. Journal of Shandong University(Health Science), 2007, 45(9): 944-946. [22] Ruijtenberg S, van den Heuvel S. Coordinating cell proliferation and differentiation: Antagonism between cell cycle regulators and cell type-specific gene expression[J]. Cell Cycle, 2016, 15(2): 196-212. [23] Shyam N, Rao NN, Narang RD, et al. Immunohistochemical characterization of cyclin dependent kinase-4 in different histological grades of oral leukoplakia and oral squamous cell carcinoma[J]. J Oral Maxillofac Pathol, 2014, 18(1): 36-41. [24] Wang X, Freire Valls A, Schermann G, et al. YAP/TAZ Orchestrate VEGF Signaling during Developmental Angiogenesis[J]. Dev Cell, 2017, 42(5): 462-478. |
[1] | 鹿向东 杨伟 徐广明 曲元明. 脑膜瘤中PPAR-γ的表达及曲格列酮对脑膜瘤培养细胞生长的影响[J]. 山东大学学报(医学版), 2209, 47(6): 65-. |
[2] | 赵舸,邹存华,宋冬冬,赵淑萍. 丹参酮IIA对子宫内膜癌细胞增殖与凋亡的影响[J]. 山东大学学报 (医学版), 2022, 60(9): 53-58. |
[3] | 任红,王伟,林岩,娄建伟,纪坤乾,赵玉英,焉传祝. Barth综合征1例报道[J]. 山东大学学报 (医学版), 2022, 60(4): 123-127. |
[4] | 卢游,且迪,伍晋辉,杨凡. 干预Sonic Hedgehog信号通路对宫内发育迟缓新生大鼠学习记忆能力的影响[J]. 山东大学学报 (医学版), 2021, 59(5): 82-89. |
[5] | 薛源,林雪艳,徐歌,田永杰. 低氧诱导因子-1α在子宫内膜异位症患者血清中的表达和对在位子宫内膜间质细胞上皮-间质转化的影响[J]. 山东大学学报 (医学版), 2021, 59(2): 41-47. |
[6] | 王正阳,夏艳,师凯旋,陶琨,王小杰. 曲美替尼在卵巢癌中对PAX8的表达作用[J]. 山东大学学报 (医学版), 2021, 59(10): 23-29. |
[7] | 杜甜甜,李娟,赵颖慧,段伟丽,王景,王允山,杜鲁涛,王传新. 长链非编码RNA LINC02474在结直肠癌中的表达特征及对细胞增殖的影响[J]. 山东大学学报 (医学版), 2021, 59(10): 57-67. |
[8] | 马青源,蒲沛东,韩飞,王超,朱洲均,王维山,史晨辉. miR-27b-3p调控SMAD1对骨肉瘤细胞增殖、迁移和侵袭作用的影响[J]. 山东大学学报 (医学版), 2020, 1(7): 32-37. |
[9] | 张宝文,雷香丽,李瑾娜,罗湘俊,邹容. miR-21-5p靶向调控TIMP3抑制2型糖尿病肾病小鼠肾脏系膜细胞增殖及细胞外基质堆积[J]. 山东大学学报 (医学版), 2020, 1(7): 7-14. |
[10] | 张晓璐,王丽莉,陈凯明,娄宪芝,张曼. 组蛋白去乙酰化酶SIRT1经Toll样受体4途径对巨噬细胞凋亡的调控[J]. 山东大学学报 (医学版), 2020, 58(12): 8-14. |
[11] | 史丽,马静,赵喜娃,关英霞,赵连梅,单保恩. miR-25-3p在40例子宫内膜腺癌组织中的表达及对KLE细胞生物学功能的影响[J]. 山东大学学报 (医学版), 2020, 58(12): 86-91. |
[12] | 毕涛,卢倩倩,孙传东. 腺病毒介导HBx对人淋巴细胞影响的体外实验[J]. 山东大学学报 (医学版), 2018, 56(7): 15-20. |
[13] | 李孝峰,杜晓益,刘海南,刘承,范医东. 小檗碱对人肾细胞癌细胞增殖、凋亡、DNA断裂及损伤修复的影响[J]. 山东大学学报 (医学版), 2018, 56(3): 54-59. |
[14] | 黄平,张坤,李芳,黄国宝,延冰,肖东杰,汪运山,刘华. 脐带和脂肪源性间充质干细胞生物学特性比较[J]. 山东大学学报 (医学版), 2018, 56(3): 72-78. |
[15] | 杨飞龙,周尊林,任巨超,闫磊,刘海南, 张温花,俞能旺,李大伟,徐忠华. 肝癌衍生生长因子对前列腺癌细胞增殖的影响及其机制[J]. 山东大学学报 (医学版), 2018, 56(1): 62-69. |
|